Article Details
Retrieved on: 2021-07-18 10:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Tezepelumab is an injectable subcutaneous monoclonal antibody that's given for patients with severe asthma, in the hope that it blocks T2 inflammation.
Article found on: www.hcplive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here